ArticleFrontiers in endocrinology2026
Risk-adapted trajectory selection for ultrasound-guided thyroid fine-needle aspiration biopsy: a multicenter study of in-plane and out-of-plane approaches.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ultrasound-guided fine-needle aspiration biopsy (FNAB) is widely used for thyroid nodule evaluation, but nondiagnostic cytology can lead to repeat procedures and delayed management. Because needle approach is influenced by nodule size, anatomical risk, access route, and needle-tip visibility, simple in-plane versus out-of-plane comparisons may not fully reflect clinical decision-making. This study evaluated the association between needle approach and diagnostic adequacy and explored whether the findings could inform a preliminary, risk-adapted trajectory-selection concept. Methods: This multicenter retrospective cohort study included 506 thyroid nodules that underwent clinically indicated ultrasound-guided FNAB between September 2024 and December 2025 at three tertiary hospitals. One center formed the primary cohort, and two independent centers formed the external validation cohort. Diagnostic adequacy was defined as Bethesda category II-VI cytology, and Bethesda category I cytology was retained in the analysis as a nondiagnostic outcome rather than excluded. Multivariable logistic regression was used to evaluate the association between needle approach and diagnostic adequacy, with adjustment for nodule size category, complex anatomical location, operator experience, and center source in pooled analyses. Stabilized inverse probability of treatment weighting was performed as a sensitivity analysis. Results: Among 506 nodules, 289 were sampled using the in-plane approach and 217 using the out-of-plane approach. Diagnostic adequacy was higher with the in-plane approach than with the out-of-plane approach (98.3% vs. 85.7%; Conclusion: The in-plane approach was associated with higher diagnostic adequacy without a statistically significant increase in immediate hematoma. These findings provide preliminary, hypothesis-generating multicenter evidence that may inform risk-adapted trajectory selection for ultrasound-guided thyroid FNAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.